Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery
Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...
top of page
it's where dermatology lives
Featured Posts
bottom of page